HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Narinder Nangia Selected Research
Narinder Nangia Research Topics
Disease
4
Opioid-Related Disorders (Opiate Addiction)
12/2020 - 01/2018
3
Major Depressive Disorder (Major Depressive Disorders)
01/2020 - 01/2019
2
Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2020 - 01/2018
2
Schizophrenia (Dementia Praecox)
01/2020 - 01/2019
1
Thrombotic Microangiopathies
01/2022
1
Relapsing-Remitting Multiple Sclerosis
11/2020
1
Weight Gain
01/2020
Drug/Important Bio-Agent (IBA)
5
Buprenorphine (Subutex)
FDA Link
Generic
12/2020 - 01/2019
5
Opioid Analgesics (Opioids)
IBA
01/2020 - 01/2018
4
Naltrexone (ReVia)
FDA Link
Generic
12/2020 - 01/2018
4
3-carboxamido-4-hydroxynaltrexone
IBA
01/2020 - 01/2019
2
Olanzapine (Zyprexa)
FDA Link
01/2020 - 01/2019
2
Narcotic Antagonists (Opioid Antagonists)
IBA
01/2020 - 01/2019
1
narsoplimab
IBA
01/2022
1
Serine (L-Serine)
FDA Link
01/2022
1
Mannose-Binding Lectin (Mannan-Binding Lectin)
IBA
01/2022
1
diroximel fumarate
IBA
11/2020
1
Fumarates
IBA
11/2020
1
Delayed-Action Preparations
IBA
01/2020
1
3,3'- di- (N- cyclopropylmethyl- 4,5- epoxy- 14- hydroxymorphinan- 6- one- 3- yl)carbonate
IBA
01/2020
1
Moxifloxacin (Avelox)
FDA Link
01/2020
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2020
Therapy/Procedure
2
Injections
12/2020 - 01/2018
1
Therapeutics
01/2022
1
Hematopoietic Stem Cell Transplantation
01/2022